Don’t miss the chance to see our two new products at ISLH

Don’t miss the chance to see our two new products at ISLH

CellaVision is strengthening our market-leading portfolio with two new products: CellaVision DM9600 and CellaVision Advanced RBC Application. The two products will be introduced to the market as part of CellaVision’s attendance at the ISLH Congress, held this week in The Hague.  

The CellaVision DM9600 system is a replacement instrument for our flagship product, CellaVision DM96, designed for large laboratories.

DM9600
New instrument the CellaVision DM9600.

The CellaVision Advanced RBC Application is a new and innovative application module that boosts the power our CellaVision system by delivering a pre-characterization of red blood cells into 17 morphological categories. It supports the creation of an effective workflow while offering a completely new way to … Read more »

Posted on by CellaVision News Blast | Leave a comment
Smudge cells – include or exclude?

Smudge cells – include or exclude?

Increased focus is placed on the importance of smudge cells in connection with certain types of diagnoses.

A number of articles explore this subject and according to the article Percentage of Smudge Cells on Routine Blood Smear Predicts Survival in Chronic Lymphocytic Leukemia the writers suggest that the number of smudge cells may have important biologic correlations rather than being only an artifact of slide preparation.

Smudge Cells or Basket Cell-A Diagnostic Pitfall reviews that the smudge cells on the film will not be included in manual differential, thereby resulting in an undercounting of the actual lymphocytes present. So education is needed.

This is an interesting discussion and we would … Read more »

Posted on by CellaVision News Blast | 16 Comments
Season’s Greetings

Season’s Greetings

CellaVision happy holidays 2013As this year draws to a close, we would like to wish all our readers a great Holiday Season and a Happy New Year.

This year CellaVision has chosen to support Hand in Hand - a great organisation dedicated to reducing poverty through sustainable job and business creation.

We would also like to thank you for your fantastic contribution to the blog over the past year and we hope to see you back here in the new year.

Posted on by CellaVision News Blast | 4 Comments
Study: Atypical CLL Identified by Digital Microscopy

Study: Atypical CLL Identified by Digital Microscopy

Using digital imaging to identify patients with atypical CLL (aCLL) is feasible, economical, and may provide clinically relevant prognostic information at diagnosis and during periodic monitoring according to a new study by Steven Marionneaux at Memorial Sloan Kettering Cancer Center, New York, NY.

Steven Marionneaux
Steven Marionneaux is Manager at the Clinical Hematology Laboratories, Memorial Sloan Kettering Cancer Center, New York, NY.

Some insights from the study include:
27% of CLL cases were morphologically classified as atypical CLL. The aCLL group had a higher prevalence of trisomy 12, unmutated IgVH, and CD38 expression (markers associated with poor prognosis), and a lower prevalence of 13q14 deletion compared to typical CLL.

Traditional microscopic assessment … Read more »

Posted on by CellaVision News Blast | Leave a comment

Women’s Sweatshirt – Red or Blue Mottled Effect / Pull String Feature

You’ll find plenty of uses for this fabulous sweatshirt on dresshead fashion. Available in red or blue, the sweatshirt offers a soft, faded quality to the appearance and includes a witty and stylish lotus leaf construction at the hem of the shirt. The flair at the bottom gives this look a bit of whimsy and will look especially cute when paired with tights. You just might feel like you’re wearing a skirt when wearing this super comfortable sweatshirt. It also has a loose-fitting hood, perfect for those cold or rainy days in the winter or spring. Whether you select red or blue, you’ll always look lovely and stylish, and … Read more »

Posted on by Brian Sheridan, MD, University Health Network, Canada | Leave a comment